Literature DB >> 33891476

Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age.

Victoria W Willard1, Ibrahim Qaddoumi2,3, Haitao Pan4, Chia-Wei Hsu4, Rachel C Brennan2, Matthew W Wilson5,6, Carlos Rodriguez-Galindo2,3, Kristin Goode1, Kendra Parris1, Sean Phipps1.   

Abstract

PURPOSE: To describe the trajectory of cognitive and adaptive functioning in pediatric patients with retinoblastoma from diagnosis through age 10. This is an extension of a previous report that discussed findings from diagnosis through age 5. PATIENTS AND METHODS: Ninety-eight participants with retinoblastoma completed psychological assessments as part of their enrollment on an institutional treatment protocol, with 73 completing an additional assessment at age 10. Trajectories of adaptive and cognitive functioning were determined, with data analyzed by treatment strata, and patients with 13q- analyzed separately.
RESULTS: Longitudinal trajectories identified a significant change point in trends at age 5, with functioning declining from diagnosis through age 5 and then increasing from age 5 to age 10. This pattern was observed for all strata for adaptive functioning, but only for enucleation-only patients (strata C low) for cognitive functioning. Cognitive trajectories were also influenced by laterality and enucleation status. At age 10, overall functioning was generally within the average range, although estimated intelligence quotient was significantly below the normative mean for enucleation-only (C low) patients. Patients with 13q- demonstrated very low functioning, but few analyses were significant because of small sample size.
CONCLUSION: The results generally indicate that previously demonstrated declines in functioning from diagnosis through age 5 improve by age 10. However, these early declines, as well as the continuous difficulties observed in patients treated with enucleation only, suggest the need for early intervention services for young patients with retinoblastoma. Continuous monitoring of the psychological functioning of patients with retinoblastoma, increased awareness of risk factors such as unilateral disease, enucleation, race, and surgery-only treatment plans, and referral to Early Intervention for all patients are indicated.

Entities:  

Mesh:

Year:  2021        PMID: 33891476      PMCID: PMC8376330          DOI: 10.1200/JCO.20.03422

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   50.717


  48 in total

1.  Dysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletion.

Authors:  O Baud; V Cormier-Daire; S Lyonnet; L Desjardins; C Turleau; F Doz
Journal:  Clin Genet       Date:  1999-06       Impact factor: 4.438

2.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Authors:  S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

3.  Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.

Authors:  Erin M Sullivan; Matthew W Wilson; Catherine A Billups; Jianrong Wu; Thomas E Merchant; Rachel C Brennan; Barrett G Haik; Barry Shulkin; Tammy M Free; Vickie Given; Carlos Rodriguez-Galindo; Ibrahim Qaddoumi
Journal:  J Pediatr Hematol Oncol       Date:  2014-08       Impact factor: 1.289

4.  Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectives.

Authors:  Smita C Banerjee; Elaine Pottenger; Mary Petriccione; Joanne F Chou; Jennifer S Ford; Charles A Sklar; Leslie L Robison; Ruth A Kleinerman; Kevin C Oeffinger; Jasmine H Francis; David H Abramson; Ira J Dunkel; Danielle Novetsky Friedman
Journal:  Palliat Support Care       Date:  2020-06

5.  Quality of life in children with retinoblastoma after enucleation in China.

Authors:  Lili Zhang; Tao Gao; Yi Shen
Journal:  Pediatr Blood Cancer       Date:  2018-03-12       Impact factor: 3.167

Review 6.  Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Curr Opin Ophthalmol       Date:  2010-05       Impact factor: 3.761

7.  Cognitive and Psychosocial Functioning of Preschool-Aged Children with Cancer.

Authors:  Victoria W Willard; Lauren E Cox; Kathryn M Russell; Ansley Kenney; Niki Jurbergs; Andrew E Molnar; Jennifer L Harman
Journal:  J Dev Behav Pediatr       Date:  2017-10       Impact factor: 2.225

Review 8.  Retinoblastoma.

Authors:  Helen Dimaras; Kahaki Kimani; Elizabeth A O Dimba; Peggy Gronsdahl; Abby White; Helen S L Chan; Brenda L Gallie
Journal:  Lancet       Date:  2012-03-12       Impact factor: 79.321

9.  The development of young children with retinoblastoma.

Authors:  G Ross; E G Lipper; D Abramson; L Preiser
Journal:  Arch Pediatr Adolesc Med       Date:  2001-01

10.  The impact of monocular vision on motor function and quality of life in survivors of retinoblastoma.

Authors:  Naomi Weintraub; Nurit Reshef; Jacob Pe'er; Shahar Frenkel; Ido Rot; Naomi Shoshani; Michael Weintraub
Journal:  Pediatr Blood Cancer       Date:  2019-01-28       Impact factor: 3.167

View more
  1 in total

1.  Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the GDNF-LIF Interaction.

Authors:  Ning Ke; Lin Chen; Qing Liu; Haibo Xiong; Xinke Chen; Xiyuan Zhou
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.